FTCDNL1
gene geneOn this page
Also known as FONG
Summary
FTCDNL1 (formiminotransferase cyclodeaminase N-terminal like, HGNC:48661) is a protein-coding gene on chromosome 2q33.1, encoding Formiminotransferase N-terminal subdomain-containing protein (E5RQL4).
Predicted to enable folic acid binding activity and transferase activity. Located in intracellular membrane-bounded organelle.
Source: NCBI Gene 348751 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001363886
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48661 |
| Approved symbol | FTCDNL1 |
| Name | formiminotransferase cyclodeaminase N-terminal like |
| Location | 2q33.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FONG |
| Ensembl gene | ENSG00000226124 |
| Ensembl biotype | protein_coding |
| OMIM | 614308 |
| Entrez | 348751 |
Gene structure
Transcript identifiers
Ensembl transcripts: 11 — 10 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000416668, ENST00000420128, ENST00000420922, ENST00000622774, ENST00000642693, ENST00000703582, ENST00000881260, ENST00000881261, ENST00000881262, ENST00000881263, ENST00000881264
RefSeq mRNA: 4 — MANE Select: NM_001363886
NM_001350853, NM_001350854, NM_001350855, NM_001363886
CCDS: CCDS86906, CCDS86907, CCDS86908, CCDS86909
Canonical transcript exons
ENST00000420128 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001653260 | 199846075 | 199846170 |
| ENSE00001662091 | 199819572 | 199819757 |
| ENSE00001725972 | 199809272 | 199812724 |
| ENSE00001790194 | 199848848 | 199848969 |
| ENSE00003719114 | 199850740 | 199851192 |
Expression profiles
Bgee: expression breadth ubiquitous, 165 present calls, max score 83.82.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 3.2791 / max 52.7256, expressed in 1061 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 33154 | 1.7093 | 793 |
| 33153 | 1.5698 | 688 |
Top tissues by expression
231 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| gastrocnemius | UBERON:0001388 | 83.82 | gold quality |
| muscle of leg | UBERON:0001383 | 83.52 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.09 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 82.02 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.80 | gold quality |
| right adrenal gland | UBERON:0001233 | 79.54 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 79.35 | gold quality |
| left adrenal gland | UBERON:0001234 | 78.21 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 78.16 | gold quality |
| adrenal tissue | UBERON:0018303 | 78.14 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 77.92 | gold quality |
| adrenal gland | UBERON:0002369 | 76.21 | gold quality |
| right lobe of liver | UBERON:0001114 | 76.00 | gold quality |
| adrenal cortex | UBERON:0001235 | 75.82 | gold quality |
| prefrontal cortex | UBERON:0000451 | 75.27 | gold quality |
| spinal cord | UBERON:0002240 | 75.22 | gold quality |
| monocyte | CL:0000576 | 74.91 | gold quality |
| leukocyte | CL:0000738 | 74.19 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 72.96 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 72.44 | gold quality |
| secondary oocyte | CL:0000655 | 72.36 | silver quality |
| thyroid gland | UBERON:0002046 | 72.29 | gold quality |
| nucleus accumbens | UBERON:0001882 | 71.64 | gold quality |
| putamen | UBERON:0001874 | 71.23 | gold quality |
| caudate nucleus | UBERON:0001873 | 70.84 | gold quality |
| islet of Langerhans | UBERON:0000006 | 70.80 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 70.80 | gold quality |
| liver | UBERON:0002107 | 70.65 | gold quality |
| right frontal lobe | UBERON:0002810 | 69.82 | gold quality |
| substantia nigra | UBERON:0002038 | 69.79 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.42 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- A single nucleotide polymorphism (SNP), rs7605378 associated with osteoporosis, was identified, in a previously unknown gene on chromosome 2q33.1, FONG. (PMID:21573128)
- results suggest that Japanese subjects homozygous for the risk alleles of rs7605378 in FONG and rs12673629 in THSD7A have a significantly higher risk of vertebral fracture (PMID:23303384)
- rs10203122 in FTCDNL1 is associated with a susceptibility to osteoporosis. (PMID:26492493)
- Two genetic variants in the HIBCH and FTCDNL1 genes are associated with susceptibility to developmental dysplasia of the hips among the Han Chinese population of Southwest China. (PMID:39113043)
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ftcdnl1 | ENSDARG00000062423 |
Paralogs (1): FTCD (ENSG00000160282)
Protein
Protein identifiers
Formiminotransferase N-terminal subdomain-containing protein — E5RQL4 (reviewed: E5RQL4)
Alternative names: Formiminotransferase-cyclodeaminase N-terminal-like protein
All UniProt accessions (4): E5RQL4, H3BMM2, H3BRX2, H3BUS8
UniProt curated annotations — full annotation on UniProt →
Tissue specificity. Widely expressed with highest levels in liver and skeletal muscle, and moderate levels in kidney, bone and pancreas.
Similarity. Belongs to the formiminotransferase family.
RefSeq proteins (4): NP_001337782, NP_001337783, NP_001337784, NP_001350815* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR012886 | Formiminotransferase_N | Domain |
| IPR022384 | FormiminoTrfase_cat_dom_sf | Homologous_superfamily |
| IPR037064 | Formiminotransferase_N_sf | Homologous_superfamily |
| IPR051623 | FTCD | Family |
Pfam: PF07837
UniProt features (2 total): signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E5RQL4-F1 | 76.93 | 0.17 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 17 (showing top):
GOMF_FOLIC_ACID_BINDING, GOMF_AMIDE_BINDING, GOMF_MODIFIED_AMINO_ACID_BINDING, GOMF_ORGANIC_ACID_BINDING, GOMF_VITAMIN_BINDING, STK33_NOMO_DN, FOXN3_TARGET_GENES, ZNF618_TARGET_GENES, ZSCAN30_TARGET_GENES, MZF1_TARGET_GENES, CUX1_TARGET_GENES, HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN, GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN, CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN, GSE2706_R848_VS_LPS_8H_STIM_DC_UP
GO Biological Process (0):
GO Molecular Function (2): folic acid binding (GO:0005542), transferase activity (GO:0016740)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| vitamin binding | 1 |
| carboxylic acid binding | 1 |
| modified amino acid binding | 1 |
| heterocyclic compound binding | 1 |
| catalytic activity | 1 |
Protein interactions and networks
STRING
300 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FTCDNL1 | TYW5 | A2RUC4 | 610 |
| FTCDNL1 | C2orf69 | Q8N8R5 | 507 |
| FTCDNL1 | ZNF823 | P16415 | 477 |
| FTCDNL1 | SPATS2L | Q9NUQ6 | 431 |
| FTCDNL1 | MAIP1 | Q8WWC4 | 417 |
| FTCDNL1 | MIMS1 | Q96ND0 | 373 |
| FTCDNL1 | THOC7 | Q6I9Y2 | 371 |
| FTCDNL1 | YAE1 | Q9NRH1 | 348 |
| FTCDNL1 | ZSCAN23 | Q3MJ62 | 348 |
| FTCDNL1 | IBA57 | Q5T440 | 348 |
| FTCDNL1 | YRDC | Q86U90 | 347 |
| FTCDNL1 | NIF3L1 | Q9GZT8 | 336 |
| FTCDNL1 | RFTN2 | Q52LD8 | 324 |
| FTCDNL1 | DNAI7 | Q6TDU7 | 324 |
| FTCDNL1 | METTL5 | Q9NRN9 | 322 |
| FTCDNL1 | GTF3C3 | Q9Y5Q9 | 322 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GPC3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A023PYH0, A6NC05, B5XXW1, B8V7P3, D4AS55, E5RQL4, F5HGC2, O36379, O36380, O36396, O74917, O75663, O98453, P0C733, P0CK47, P0CK48, P0CK56, P0CK57, P15200, P21005, P21071, P21106, P24756, P43151, P54446, P68960, P68961, P92551, Q00058, Q01031, Q196U3, Q1HVB5, Q20A00, Q2V4N5, Q32M92, Q37884, Q495D7, Q66670, Q76ZJ3, Q77374
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1960 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:199760833:CCA:C | acceptor_gain | 1.0000 |
| 2:199760834:CA:C | acceptor_gain | 1.0000 |
| 2:199760834:CAC:C | acceptor_gain | 1.0000 |
| 2:199760836:C:CC | acceptor_gain | 1.0000 |
| 2:199812636:G:C | donor_gain | 1.0000 |
| 2:199819659:T:TA | donor_gain | 1.0000 |
| 2:199844378:A:AC | donor_gain | 1.0000 |
| 2:199844379:C:CC | donor_gain | 1.0000 |
| 2:199844379:CTT:C | donor_gain | 1.0000 |
| 2:199844408:TGTGA:T | donor_gain | 1.0000 |
| 2:199846069:TCTTA:T | donor_loss | 1.0000 |
| 2:199846070:CTTA:C | donor_loss | 1.0000 |
| 2:199846071:TTA:T | donor_loss | 1.0000 |
| 2:199846072:TA:T | donor_loss | 1.0000 |
| 2:199846073:A:AC | donor_gain | 1.0000 |
| 2:199846073:AC:A | donor_gain | 1.0000 |
| 2:199846073:ACCC:A | donor_loss | 1.0000 |
| 2:199846074:C:CC | donor_gain | 1.0000 |
| 2:199846074:C:G | donor_loss | 1.0000 |
| 2:199846074:CC:C | donor_gain | 1.0000 |
| 2:199846074:CCCAA:C | donor_gain | 1.0000 |
| 2:199846078:A:C | donor_gain | 1.0000 |
| 2:199846083:T:C | donor_gain | 1.0000 |
| 2:199846166:CTTTC:C | acceptor_gain | 1.0000 |
| 2:199846167:TTTC:T | acceptor_gain | 1.0000 |
| 2:199846168:TTC:T | acceptor_gain | 1.0000 |
| 2:199846169:TC:T | acceptor_gain | 1.0000 |
| 2:199846169:TCC:T | acceptor_loss | 1.0000 |
| 2:199846170:CC:C | acceptor_gain | 1.0000 |
| 2:199846171:C:CA | acceptor_loss | 1.0000 |
AlphaMissense
885 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:199819642:G:C | F109L | 0.965 |
| 2:199819642:G:T | F109L | 0.965 |
| 2:199819644:A:G | F109L | 0.965 |
| 2:199819711:A:C | F86L | 0.961 |
| 2:199819711:A:T | F86L | 0.961 |
| 2:199819713:A:G | F86L | 0.961 |
| 2:199846133:A:C | F51L | 0.956 |
| 2:199846133:A:T | F51L | 0.956 |
| 2:199846135:A:G | F51L | 0.956 |
| 2:199819660:C:A | R103S | 0.954 |
| 2:199819660:C:G | R103S | 0.954 |
| 2:199819705:A:C | F88L | 0.928 |
| 2:199819705:A:T | F88L | 0.928 |
| 2:199819707:A:G | F88L | 0.928 |
| 2:199819661:C:G | R103T | 0.918 |
| 2:199819647:A:G | W108R | 0.909 |
| 2:199819647:A:T | W108R | 0.909 |
| 2:199819663:T:A | R102S | 0.897 |
| 2:199819663:T:G | R102S | 0.897 |
| 2:199819717:G:C | S84R | 0.876 |
| 2:199819717:G:T | S84R | 0.876 |
| 2:199819719:T:G | S84R | 0.876 |
| 2:199819657:C:A | K104N | 0.868 |
| 2:199819657:C:G | K104N | 0.868 |
| 2:199819643:A:G | F109S | 0.852 |
| 2:199819645:C:A | W108C | 0.851 |
| 2:199819645:C:G | W108C | 0.851 |
| 2:199819661:C:A | R103M | 0.850 |
| 2:199846104:A:G | I61T | 0.842 |
| 2:199819712:A:G | F86S | 0.837 |
dbSNP variants (sampled 300 via entrez): RS1000015865 (2:199680573 C>T), RS1000020494 (2:199743693 T>C), RS1000026285 (2:199727223 C>T), RS1000042254 (2:199714185 C>G), RS1000045361 (2:199791667 C>T), RS1000045755 (2:199839947 C>G), RS1000070175 (2:199716902 A>G), RS1000077607 (2:199704392 T>C,G), RS1000096588 (2:199797389 A>G), RS1000137414 (2:199720511 C>T), RS1000148996 (2:199796967 T>C), RS1000183602 (2:199850492 T>C), RS1000190897 (2:199765103 G>A), RS1000197398 (2:199671692 C>A), RS1000211311 (2:199768387 A>C)
Disease associations
OMIM: gene MIM:614308 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001071_1 | Osteoporosis | 2.000000e-08 |
| GCST002149_16 | Schizophrenia | 1.000000e-08 |
| GCST004521_125 | Autism spectrum disorder or schizophrenia | 3.000000e-12 |
| GCST004946_83 | Schizophrenia | 2.000000e-16 |
| GCST006803_6 | Schizophrenia | 4.000000e-17 |
| GCST007201_274 | Schizophrenia | 5.000000e-14 |
| GCST007201_36 | Schizophrenia | 1.000000e-14 |
| GCST008595_64 | Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) | 3.000000e-13 |
| GCST010151_6 | Carotid intima media thickness x smoking interaction | 3.000000e-07 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
| EFO:0004784 | self reported educational attainment |
| EFO:0006527 | smoking status measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| mono-(2-ethylhexyl)phthalate | increases abundance, increases methylation | 1 |
| clothianidin | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Diethylhexyl Phthalate | increases abundance, increases methylation | 1 |
| Formaldehyde | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): osteoporosis